Osaic Holdings’s CASI Pharmaceuticals CASI Stock Holding History

Osaic Holdings’s Portfolio CASI Stock Details CASI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-8	Closed	-$49	–	7429
2024 Q3	$49	Hold	8	–	–	﹤0.01%	7299
2024 Q2	$44	Buy	+8	New	+$25	﹤0.01%	7307
2023 Q1	–	Sell	-200	Closed	–	–	7503
2022 Q4	$0	Hold	200	–	–	﹤0.01%	7194
2022 Q3	$1K	Hold	200	–	–	﹤0.01%	6951
2022 Q2	$1K	Hold	200	–	–	﹤0.01%	7042
2022 Q1	$2K	Hold	200	–	–	﹤0.01%	6853
2021 Q4	$2K	Hold	200	–	–	﹤0.01%	6986
2021 Q3	$2K	Hold	200	–	–	﹤0.01%	6833
2021 Q2	$3K	Hold	200	–	–	﹤0.01%	6579
2021 Q1	$5K	Hold	200	–	–	﹤0.01%	6134
2020 Q4	$6K	Hold	200	–	–	﹤0.01%	5698
2020 Q3	$3K	Hold	200	–	–	﹤0.01%	5707
2020 Q2	$5K	Hold	200	–	–	﹤0.01%	5453
2020 Q1	$4K	Buy	+200	New	+$4.77K	﹤0.01%	5418

Other funds holding CASI

FCMV

Foresite Capital Management VI Larkspur, California $643M AUM 343.43% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

WSCM

Wellington Shields Capital Management New York $788M AUM 66.95% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

WSC

Wellington Shields & Co New York $446M AUM 38.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Osaic Holdings's CASI Position: Q4 2024 in Review

Osaic Holdings sold out of CASI Pharmaceuticals (CASI) in Q4 2024, closing a stake of 8 shares — an estimated $49 sold.

Osaic Holdings first reported a position in CASI in Q1 2020 and held it in 14 quarters. The position peaked at $6K in Q4 2020. 22 funds tracked by Wall St. Rank hold CASI as of Q4 2024.

Osaic Holdings reported no remaining CASI Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
Osaic Holdings sold 8 CASI Pharmaceuticals shares in Q4 2024, an estimated $49.
Osaic Holdings first reported a position in CASI Pharmaceuticals in Q1 2020 and held it in 14 quarters.
Osaic Holdings's CASI Pharmaceuticals position peaked at $6K in Q4 2020.
22 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q4 2024.

Based on Osaic Holdings's 13F filing for Q4 2024, filed 7 Feb 2025.